Tribute Pharmaceuticals Canada Inc. Research and Development Expense
Tribute Pharmaceuticals Canada Inc. reported Research and Development Expense of CAD 21.40 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-03-31
- Tribute Pharmaceuticals Canada Inc. research and development expense for the quarter ending 2012-12-31 was 6.49K CAD, a 61.71% increase year-over-year.
- Tribute Pharmaceuticals Canada Inc. research and development expense for the quarter ending 2012-09-30 was 6.59K CAD, a 45.97% decline year-over-year.
- Tribute Pharmaceuticals Canada Inc. research and development expense for the quarter ending 2012-06-30 was 6.57K CAD, a 67.28% decline year-over-year.
- Tribute Pharmaceuticals Canada Inc. research and development expense for the quarter ending 2012-03-31 was 1.75K CAD.
- Tribute Pharmaceuticals Canada Inc. research and development expense for fiscal 2012 was 21.40K CAD, a 57.18% decline from fiscal 2011.
- Tribute Pharmaceuticals Canada Inc. research and development expense for fiscal 2011 was 49.98K CAD.
CAD
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | 6.49K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 13.08K CAD derived: sum of 2 quarters · filed 2014-03-31 | 19.65K CAD derived: sum of 3 quarters · filed 2014-03-31 | 21.40K CAD 10-K · filed 2014-03-31 |
| 2012-09-30 | 6.59K CAD 10-Q · filed 2013-11-14 | 13.16K CAD derived: sum of 2 quarters · filed 2013-11-14 | 14.92K CAD 10-Q · filed 2013-11-14 | 18.93K CAD derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | 6.57K CAD 10-Q · filed 2013-08-13 | 8.33K CAD 10-Q · filed 2013-08-13 | 12.34K CAD derived: sum of 3 quarters · filed 2013-08-13 | 24.53K CAD derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | 1.75K CAD 10-Q · filed 2013-05-14 | 5.76K CAD derived: sum of 2 quarters · filed 2013-05-14 | 17.96K CAD derived: sum of 3 quarters · filed 2013-05-14 | 38.05K CAD derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | 4.01K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | 16.21K CAD derived: sum of 2 quarters · filed 2013-03-22 | 36.30K CAD derived: sum of 3 quarters · filed 2013-03-22 | 49.98K CAD 10-K · filed 2013-03-22 |
| 2011-09-30 | 12.20K CAD 10-Q · filed 2012-11-14 | 32.29K CAD derived: sum of 2 quarters · filed 2012-11-14 | 45.97K CAD 10-Q · filed 2012-11-14 | |
| 2011-06-30 | 20.09K CAD 10-Q/A · filed 2012-09-13 | 33.77K CAD 10-Q/A · filed 2012-09-13 |
USD
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $1.75K 10-Q · filed 2012-05-15 | $5.76K derived: sum of 2 quarters · filed 2012-05-15 | $17.96K derived: sum of 3 quarters · filed 2012-05-15 | $38.05K derived: sum of 4 quarters · filed 2012-05-15 |
| 2011-12-31 | $4.01K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-03 | $16.21K derived: sum of 2 quarters · filed 2012-04-03 | $36.30K derived: sum of 3 quarters · filed 2012-04-03 | $49.98K 10-K · filed 2012-04-03 |
| 2011-09-30 | $12.20K 10-Q · filed 2011-11-14 | $32.29K derived: sum of 2 quarters · filed 2011-11-14 | $45.97K 10-Q · filed 2011-11-14 | $79.88K derived: sum of 4 quarters · filed 2012-05-15 |
| 2011-06-30 | $20.09K 10-Q/A · filed 2011-08-22 | $33.77K 10-Q/A · filed 2011-08-22 | $67.68K derived: sum of 3 quarters · filed 2012-05-15 | $113.29K derived: sum of 4 quarters · filed 2012-05-15 |
| 2011-03-31 | $13.68K 10-Q · filed 2012-05-15 | $47.59K derived: sum of 2 quarters · filed 2012-05-15 | $93.19K derived: sum of 3 quarters · filed 2012-05-15 | $102.88K derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $33.91K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-03 | $79.52K derived: sum of 2 quarters · filed 2012-04-03 | $89.20K derived: sum of 3 quarters · filed 2012-04-03 | $115.47K 10-K · filed 2012-04-03 |
| 2010-09-30 | $45.61K 10-Q · filed 2011-11-14 | $55.29K derived: sum of 2 quarters · filed 2011-11-14 | $81.56K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $9.68K 10-Q/A · filed 2011-08-22 | $35.95K 10-Q/A · filed 2011-08-22 |